Bitterroot Bio
32 employees
Biotech/Pharma
Series A · $145.0M
Open positions (1)
Company details
Team Size32
IndustryBiotech/Pharma
Funding
Total raised
$145.0M
Last stage
Series A
Investors
GV
Total raised
$145.0M
Last stage
Series A
Investors
Irving L. Weissman
Professor of Biology and Founding Director of the Institute for Stem Cell Biology and Regenerative Medicine at Stanford University; Member, National Academy of Sciences. Previously co-founded Forty Seven, Inc. (acquired by Gilead for ~$5B in 2020).
Nicholas Leeper
MD; Chief of Vascular Medicine, Professor, and Director of Vascular Research at Stanford University. Co-founded Bitterroot Bio based on his CD47 cardiovascular disease research.
Lou Lange
MD, PhD; General Partner at Asset Management Ventures; former Chairman and CEO of CV Therapeutics.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.